A. Alexakis et al.
FULL PAPER
warm to room temperature, and maintained under these conditions
0.54 (s, 3 H, CH3-T), 0.89 [s, 9 H, (CH3)3C], 1.01 (s, 3 H,
for 3 h. It was then cooled to Ϫ70 °C once more, whereupon neat CH3-T), 5.33 (d, J ϭ 8.5 Hz, 1 H, 7-H), 6.12 (d, J ϭ 8.5 Hz,
MeOPCl2 was added dropwise at such a rate as to keep the internal
temperature below Ϫ70 °C. The resulting mixture was allowed to
warm to room temperature, stirred for 1 h, and then the solvent
was removed in vacuo. The resulting semi-solid residue was stirred
with toluene (10 mL) for 1 h and then filtered through Celite. The
solvent was subsequently removed in vacuo; purification of the res-
idue by flash chromatography (cyclohexane/diethyl ether/triethyla-
mine, 95:5:1) followed by crystallization from pentane furnished the
title compound as a white crystalline solid (1.13 g, 2.1 mmol, 86%);
1 H, 1-H), 7.15Ϫ6.99 (m, 10 H, ArH), 7.89Ϫ7.68 (m, 10 H, ArH).
Ϫ
13C NMR: δ ϭ 26.3, 27.1, 30.1, 30.2, 77.6, 80.2, 80.3, 82.6, 82.9,
83.5, 83.6, 84.8, 85.0, 112.3 (C-9), 127.1, 127.3, 127.4, 127.7, 127.8,
127.9, 129.2, 129.5, 142.5, 142.8, 147.1. Ϫ 31P NMR: δ ϭ 132.33.
Ϫ MS (CI, NH3): m/z (%) ϭ 585 [M ϩ 16 ϩ H]ϩ (5). Ϫ C35H37O5P
(568.6): calcd. C 73.93, H 6.56; found C 73.77, H 6.96.
(1R,7R)-9,9-Dimethyl-2,2,6,6-tetraphenyl-4-phenyloxy-3,5,8,10-
tetraoxa-4-phosphabicyclo[5.3.0]decane (4); Method C: Preparation
according to the literature.[18] To a stirred solution of (Ϫ)-T
(1.16 g, 2.5 mmol) in THF (10 mL) at Ϫ70 °C was added butylli-
thium (3.4 mL of a 1.5 solution in hexanes, 5.13 mmol) at such
a rate as to keep the internal temperature below Ϫ60 °C. The reac-
tion mixture was stirred at Ϫ70 °C for 10 min, then allowed to
warm to room temperature, and maintained under these conditions
for 3 h. It was then cooled to Ϫ70 °C once more, whereupon neat
PhOPCl2 was added dropwise so as to keep the internal temper-
ature below Ϫ60 °C. The resulting mixture was allowed to warm
to room temperature, stirred for 18 h (for convenience), and then
the solvent was removed in vacuo. The resulting semi-solid residue
was stirred with toluene (10 mL) for 1 h and then filtered through
Celite. The solvent was removed in vacuo and purification of the
residue by flash chromatography (cyclohexane/diethyl ether/tri-
ethylamine, 95:5:1) followed by crystallization from pentane fur-
nished the title compound as a white solid (1.17 g, 1.99 mmol,
m.p. 189Ϫ191 °C (from pentane) (ref.[19] 190Ϫ192 °C). Ϫ [α]1D8
ϭ
Ϫ223 (c ϭ 1.05 in CH2Cl2) {ref.[18] [α]rD.t. ϭ Ϫ236.7 (c ϭ 1.17 in
1
CHCl3)}. Ϫ H NMR: δ ϭ 0.61 (s, 3 H, CH3-T), 0.88 (s, 3
H, CH3-T), 3.28 (d, 3 H, CH3O), 5.49 (dd, J ϭ 8.2 and
1.5 Hz, 1 H, 7-H), 5.62 (d, J ϭ 8.2 Hz, 1 H, 1-H), 7.12Ϫ6.95 (m,
12 H, ArH), 7.82Ϫ7.66 (m, 8 H, ArH). Ϫ 13C NMR: δ ϭ 26.6,
27.2, 49.4, 81.5, 82.8, 82.9, 83.4, 85.9, 86.0, 113.3 (C-9), 128.3,
129.3, 142.2, 146.8, 147.0. Ϫ 31P NMR: δ ϭ 133.80.
(1R,7R)-4-Cyclohexyloxy-9,9-dimethyl-2,2,6,6-tetraphenyl-3,5,8,10-
tetraoxa-4-phosphabicyclo[5.3.0]decane (2); Method A: To a stirred
solution of (Ϫ)-T (1.16 g, 2.5 mmol) and triethylamine
(1.24 mL, 8.5 mmol) in THF (10 mL) at 0 °C was slowly added
PCl3 (236 µL, 2.6 mmol). A white precipitate was deposited and
the resulting mixture was stirred at room temperature for 10 min
and then cooled to 0 °C once more. A solution of cyclohexanol
(270 mg, 2.7 mmol) in THF (10 mL) was then added and stirring
was continued for 1 h at room temperature. The reaction mixture
was diluted with diethyl ether and filtered through a pad of Celite.
The solvent was removed in vacuo, and the residue was taken-up
in diethyl ether and filtered through Celite; this procedure was re-
peated until addition of ether produced a clear solution. Purifica-
tion by flash chromatography (cyclohexane/diethyl ether/triethyl-
amine, 95:5:1) followed by crystallization from a mixture of diethyl
ether and pentane furnished the title compound as a white solid
(693 mg, 1.16 mmol, 47%); m.p. 189Ϫ191 °C (pentane/diethyl
80%); m.p. 178Ϫ179 °C (pentane) (ref.[18] 177Ϫ177.5 °C). Ϫ [α]1D8
ϭ
Ϫ167.2 (c ϭ 1.36 in CHCl3) {ref.[19] [α]1D8 ϭ Ϫ172.8 (c ϭ 1.09 in
1
CHCl3)}. Ϫ H NMR: δ ϭ 0.70 (s, 3 H, CH3-T), 0.79 (s, 3
H, CH3-T), 5.13 (d, J ϭ 8.3 Hz, 1 H, 7-H), 5.59 (d, J ϭ
8.3 Hz, 1 H, 1-H), 6.58 (d, J ϭ 8.3 Hz, 2 H, ArH), 7.63Ϫ7.01 (m,
23 H, ArH). Ϫ 13C NMR: δ ϭ 26.9, 27.0, 80.6, 82.5, 82.6, 85.4,
86.6, 113.5 (C-9), 120.3, 120.4, 127.6, 128.3, 129.1, 129.4, 129.5,
141.7, 146.3, 152.5. Ϫ 31P NMR: δ ϭ 128.12.
(1R,7R)-9,9-Dimethyl-4-hydrido-4-oxo-2,2,6,6-tetraphenyl-3,5,8,10-
tetraoxa-4-phosphabicyclo[5.3.0]decane (5): This compound was
isolated from various ligand preparations as a white crystalline
solid; m.p. 226Ϫ227 °C (decomp.) (pentane/diethyl ether). Ϫ
1
ether). Ϫ [α]1D8 ϭ Ϫ154.8 (c ϭ 0.75 in CHCl3). Ϫ H NMR: δ ϭ
0.65 (s, 3 H, CH3-T), 0.93 (s, 3 H, CH3-T), 1.34Ϫ1.12
(m, 6 H, cyclohexyl), 1.70Ϫ1.58 (m, 3 H, cyclohexyl), 1.81Ϫ1.75
(br. m, 1 H, cyclohexyl), 4.28Ϫ4.22 (m, 1 H, CHO-cyclohexyl), 5.07
(dd, J ϭ 8.3 and 1.4 Hz, 1 H, 7-H), 5.29 (d, 1 H, J ϭ 8.3 Hz, 1-
H), 7.37Ϫ7.28 (m, 12 H, ArH), 7.63Ϫ7.50 (m, 8 H, ArH). Ϫ 13C
NMR: δ ϭ 23.9, 25.3, 26.2, 26.8, 34.1, 73.3, 73.4, 81.1, 82.2, 82.5,
84.4, 84.5, 112.3 (C-9), 127.0, 127.2, 127.4, 127.7, 128.0, 128.7,
129.0, 141.7, 146.4. Ϫ 31P NMR: δ ϭ 134.10. Ϫ MS (CI, NH3):
m/z (%) ϭ 595 [M ϩ H]ϩ (Ͻ 1), 373 (100). Ϫ C37H39O5P (594.7)
calcd. C 74.73, H 6.61; found C 74.88, H 6.76.
1
[α]1D8 ϭ Ϫ289.9 (c ϭ 1.56 in CHCl3). Ϫ H NMR: δ ϭ 0.59 (s, 3
H, CH3-T), 0.79 (s, 3 H, CH3-T), 5.24 (d, J ϭ 8.0 Hz,
1 H, 7-H), 5.38 (d, J ϭ 8.0 Hz, 1 H, 1-H), 7.12 (d, J ϭ 7.3 Hz, 1
H, 4-H), 7.45Ϫ7.30 (m, 16 H, ArH), 7.65Ϫ7.61 (m, 4 H, ArH). Ϫ
13C NMR: δ ϭ 28.2, 28.7, 81.7, 72.0, 90.6, 90.7, 116.3 (C-9), 128.7,
128.8, 130.3, 130.6, 130.7, 145.1, 145.6. Ϫ 31P NMR: δ ϭ Ϫ3.13.
Ϫ MS (CI, NH3): m/z (%) ϭ 530 [M ϩ NH4]ϩ (1), 431 (100). Ϫ
C31H29O5P (512.5): calcd. C 72.65, H 5.70; found C 72.51, H 5.68.
(1R,7R)-9,9-Dimethyl-2,2,6,6-tetraphenyl-4-(1,3,3-trimethylbicyclo-
[2.2.1]hept-2-yloxy)-3,5,8,10-tetraoxa-4-phosphabicyclo[5.3.0]decane
(6); Method B: To a stirred solution of (ϩ)-fenchol (0.77 g,
5.0 mmol) in THF (5 mL) was slowly added PCl3 (436 µL,
(1R,7R)-4-(tert-Butyloxy)-9,9-dimethyl-2,2,6,6-tetraphenyl-3,5,8,10-
tetraoxa-4-phosphabicyclo[5.3.0]decane (3); Method B: To a stirred
solution of PCl3 (218 µL, 2.5 mmol) and triethylamine (1.08 mL,
7.8 mmol) in THF (10 mL) at 0 °C, a solution of tert-butyl alcohol 5.0 mmol) as a solution in THF (4 mL, 1 mL rinse) and the re-
(185 mg, 2.5 mmol) in THF (10 mL, 1 mL rinse) was added over a
period of 0.5 h. The reaction mixture was then allowed to warm to
ambient temperature and maintained under these conditions for
1.5 h. Solid (Ϫ)-T (1.16 g, 2.5 mmol) was then added and
stirring was continued for 1.5 h. Diethyl ether was added, the re-
sulting precipitate was removed by filtration through Celite, and
the solvent removed in vacuo. Purification of the residue by flash
chromatography (cyclohexane/EtOAc/triethylamine, 95:5:1) fol-
lowed by crystallization from pentane furnished the title compound
as a white solid (1.22 g, 2.15 mmol, 86%); m.p. 174Ϫ176 °C (pen-
tane). Ϫ [α]1D8 ϭ Ϫ133.4 (c ϭ 1.06 in CHCl3). Ϫ 1H NMR: δ ϭ
sulting mixture was stirred for 1 h. Thereafter, 31P NMR indicated
the presence of fencholϪPCl2 (δ ϭ 174.60). The reaction mixture
was then cooled to Ϫ10 °C and triethylamine (2.08 mL, 15 mmol)
was slowly added. A slightly exothermic process was noted, accom-
panied by the formation of a white precipitate. The reaction mix-
ture was allowed to warm to room temperature, maintained under
these conditions for 0.25 h, and then cooled to 0 °C. Solid (Ϫ)-
T was added, the reaction mixture allowed to warm to room
temperature, and stirring was continued for 2 h prior to dilution
with diethyl ether. The solids were removed by filtration through a
pad of Celite, the solvent was removed in vacuo, and the residue
4018
Eur. J. Org. Chem. 2000, 4011Ϫ4027